Carlin Teresa M, Chanmugam Arjun
Johns Hopkins Hospital, 600 North Wolfe Street, Marburg B187A, Baltimore, MD 21287-2080, USA.
Emerg Med Clin North Am. 2002 Aug;20(3):671-85. doi: 10.1016/s0733-8627(02)00017-2.
Childhood stroke is an infrequent occurrence. Children with sickle cell disease and congenital heart disease are particularly vulnerable. The recognition of stroke in children, unlike adults, is typically delayed by healthcare providers and family members. Large, multicentered pediatric stroke trials are absent in the literature. These studies are difficult to perform because the event is rare and the causes are numberous. Adverse outcomes such as death and reoccurrence could be reduced with defined treatment options. Pediatric stroke protocols are largely extrapolated from the adult literature. The use of treatment strategies such as thrombolytic therapy, aspirin, and anticoagulation are controversial at present.
儿童中风并不常见。患有镰状细胞病和先天性心脏病的儿童尤其易患。与成人不同，儿童中风通常会被医疗保健人员和家庭成员延误识别。文献中缺乏大型、多中心的儿科中风试验。由于该事件罕见且病因众多，这些研究很难开展。通过明确的治疗方案可以减少死亡和复发等不良后果。儿科中风治疗方案大多是从成人文献中推断出来的。目前，溶栓治疗、阿司匹林和抗凝等治疗策略的使用存在争议。
